TrialLupus2025

The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis.

Susan Manzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.